FindTrial
Sign In

Comparative study on the effects of oral and microscopic spraying of simethicone in bowel preparation

Comparative study on the effects of oral and microscopic spraying of simethicone in bowel preparation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043942
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-03-29
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Interventions

experiment group:PEG orally + endoscopic spraying simethicone oil
control group:simethicone oil combined with PEG orally
control group2:Oral PEG

Sponsors

Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (i) no contraindication to colonoscopy or to taking PEG or simethicone oil; (ii) good compliance; (iii) aged 18-65 years.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women, and women who have the opportunity to become pregnant; (2) Presence of severe cardiopulmonary or hepatic or renal insufficiency; (3) Contraindication to the administration of simethicone or PEG; (4) Psychiatric abnormalities; (5) Those who have undergone colon surgery; (6) Those who have undergone other clinical trials within 60 days.

Design outcomes

Primary

MeasureTime frame
the quality of bowel cleansing;adenoma detection rate;Intestinal bubble grading;—

Secondary

MeasureTime frame
Degree of abdominal distension;—

Countries

China

Contacts

Public ContactPeng Jin

Seventh Medical Center of PLA General Hospital

dr_pengjin@qq.com+86 13466671195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026